Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.


OBJECTIVES Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer deaths worldwide. Increasing levels of visfatin are correlated with worse clinical prognosis of NSCLC. However, the effects of visfatin on drug resistant are still not well illustrated. MATERIALS AND METHODS Effects of visfatin on drug resistant cells were checked by CCK… (More)
DOI: 10.1111/cpr.12366


  • Presentations referencing similar topics